Although a metaanalysis from 2013 did not produce a significant result, it did conclude that the influence of oral contraception on the risk of breast cancer in women with pV in BRCA1/2 genes is comparable to that in women in the general population (Moorman et al. 2013). The gene discussed is BRCA1; the disease is breast carcinoma.